INS and type 1 diabetes mellitus: Standard of care involves tight management of glycaemic control through life-long insulin therapy, but optimal metabolic management needed to prevent acute (e.g. ketoacidosis and severe hypoglycaemia) and chronic (e.g. retinopathy, nephropathy and heart disease) complications is not achieved in most people living with type 1 diabetes [2–5].